BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38212708)

  • 1. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
    Li X; Li J; Li J; Liu N; Zhuang L
    BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.
    Xiao Y; Zhang G; Wang L; Liang M
    Front Endocrinol (Lausanne); 2022; 13():1069528. PubMed ID: 36518242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the overall survival prognosis prediction accuracy: A 9-gene signature¬†in CRC patients.
    Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
    Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
    Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
    Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer.
    Hong J; Lin X; Hu X; Wu X; Fang W
    Curr Gene Ther; 2021; 21(4):280-289. PubMed ID: 33045967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Biomarkers Associated with the Prognoses of Colorectal Cancer Patients.
    Fang Y; Zhan X
    Digestion; 2023; 104(2):148-162. PubMed ID: 36577392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis.
    Wang XQ; Xu SW; Wang W; Piao SZ; Mao XL; Zhou XB; Wang Y; Wu WD; Ye LP; Li SW
    Front Genet; 2021; 12():635863. PubMed ID: 33719345
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.